Efficacy and safety of macitentan in Fontan-palliated patients: 52-week randomized, placebo-controlled RUBATO Phase 3 trial and open-label extension.
Clift P, Berger F, Sondergaard L, Antonova P, Disney P, Nicolarsen J, Thambo JB, Tomkiewicz Pajak L, Wang JK, Schophuus Jensen A, Efficace M, Friberg M, Haberle D, Walter V, d'Udekem Y.
Clift P, et al. Among authors: berger f.
J Thorac Cardiovasc Surg. 2025 Feb;169(2):385-394.e5. doi: 10.1016/j.jtcvs.2024.08.039. Epub 2024 Aug 29.
J Thorac Cardiovasc Surg. 2025.
PMID: 39216715
Free article.
Clinical Trial.